MStranslate

03/09/2026

A new small study from UCLA has found that a combination of the hormones estriol and progesterone may improve cognitive outcomes in menopausal women. Previous research from the same group has also shown that estriol may have beneficial effects for women living with multiple sclerosis (MS).

Given the growing interest in understanding how menopause affects women with MS, this emerging area of research is particularly interesting. It will be important to follow future studies to see whether these findings can be replicated and whether hormone therapy could eventually become a viable treatment approach for managing cognitive changes associated with menopause and MS.

02/09/2026

BREAKING NEWS: Novartis has announced positive Phase 3 trial results for their BTK inhibitor, remibrutinib, in people living with relapsing multiple sclerosis. While the full results will be presented at MSToronto2026 in October, the press release has stated that the treatment resulted in a reduction in relapses and a delay in disease progression, while also having a good safety profile. We will provide a full summary of these trial results after they are presented at the conference next month.

Press release: https://www.novartis.com/news/media-releases/novartis-remibrutinib-high-efficacy-oral-btk-inhibitor-significantly-reduces-relapse-rates-and-shows-favorable-safety-profile-phase-iii-rms-trials

28/08/2026

Recent studies suggest that up to 65% of people living with multiple sclerosis will experience depression at some point after diagnosis. This results in a lower quality of life, as well as worsening symptoms like fatigue and cognition. It is important to note that help and support is available and you don't have to go through it alone and in silence. If you are struggling with your mental health this weekend, please reach out to someone. If you are doing well, please also reach out to someone else in your community and ask if they are doing ok. We are stronger together.

26/08/2026

Dolly Parton passed away today aged 80. While best known for her music, she will also be remembered for the lasting impact that she had on research and public health. Through her philanthropy and her advocacy, she helped make scientific research meaningful and fought tirelessly against medical misinformation. We thank her for the remarkable contribution and for using her platform to champion good science and scientific communication. She will be deeply missed.

Picture credit: ABC Science

25/08/2026

New research funded by MS Australia and conducted at the Menzies Institute for Medical Research has provided new insights into sleep dysfunction in multiple sclerosis and the impacts that it has on symptoms and employment. These findings further highlight why managing sleep should be an important part of MS care.

Australian research suggests some prescription medications may worsen sleep quality in people with MS. Better sleep may improve MS symptoms, work productivity and overall quality of life.

24/08/2026

It is just under 2 months until ECTRIMS Patient Community Day! We want as many people as possible from around the world to participate. As Dr Anne Helme from Multiple Sclerosis International Federation explains, the involvement of people living with multiple sclerosis in this event is critical for the progression of MS research.

Register here: https://www.ectrimspatientcommunity.eu/registration

European Committee for Treatment & Research in Multiple Sclerosis ACTRIMS

19/08/2026

How is technology changing the way that multiple sclerosis is diagnosed, treated and managed? Will artificial intelligence, wearable devices and other advances make a meaningful difference to the lives of people living with MS? This topic was explored in the latest European Committee for Treatment & Research in Multiple Sclerosis podcast, which you can listen to at the link below.

Listen now: https://ectrims.eu/podcast/how-medical-technology-is-transforming-multiple-sclerosis-care/

18/08/2026

A newly published study has investigated the use of cannabis-derived treatments to manage spasticity in people living with multiple sclerosis. The study looked at nabiximols (a cannabis-derived mouth spray) and cannabis decoctions (also known as cannabis tea) and found that both were effective at reducing spasticity, spasms and pain. As some people can struggle to tolerate nabiximols, it was suggested that cannabis tea could be a good alternative. Larger studies are now needed to confirm these findings and develop the best treatment strategies.

17/08/2026

VOTE NOW: Spasticity is a symptom that I commonly experience as part of living with multiple sclerosis (react with WOW for YES or LOVE for NO)

15/08/2026

An interesting new study from the Max Planck Institute in Munich has identified that corticotropin-releasing hormone (CRH), which is usually released in relation to stress, may be important for remyelination. While exciting, this research is at a very early stage, so more work is needed before we understand exactly how this finding may be used to help develop myelin repair therapies.

A stress hormone helps repair injuries in the brain. Researchers have discovered a mechanism for protecting nerve cells that may be relevant to the development of psychiatric disorders.